Syntacoll, our medical-grade collagen CDMO division of Innocoll, will be an exhibitor at CPHI Barcelona from October 24th - 26th. We hope to see you there and be sure to visit Booth 80N30 to find out more about our collagen production and R&D capabilities and services! #Innocoll #Syntacoll #CPHI
关于我们
Innocoll is committed to improving patient care by confronting some of today’s most important healthcare challenges. Everyone at Innocoll is united by a common goal: to deliver healthcare solutions that make a difference in patients’ lives. We take pride in fostering a culture of collaboration, and we strive to be the best possible partners to the hospitals and doctors we support. Our current late-stage product pipeline, including XARACOLL (bupivacaine HCl) implant and POSIMIR (bupivacaine solution) for infiltration use, are focused on addressing patient needs for postsurgical pain management.
- 网站
-
https://www.innocoll.com
Innocoll Biotherapeutics的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Princeton,New Jersey
- 类型
- 私人持股
- 创立
- 1985
- 领域
- Pharmaceutical、Targeted Drug Delivery、Collagen-based Technologies和Medical Device